Aspiriant LLC’s Bank of New York Mellon BNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Buy
+1,435
New +$196K 0.01% 381
2020
Q1
Sell
-4,902
Closed -$247K 189
2019
Q4
$247K Buy
4,902
+377
+8% +$18K 0.02% 186
2019
Q3
$205K Hold
4,525
0.02% 208
2019
Q2
$200K Sell
4,525
-320
-7% -$15K 0.02% 223
2019
Q1
$245K Sell
4,845
-1,257
-21% -$64.8K 0.02% 203
2018
Q4
$287K Buy
6,102
+296
+5% +$14.4K 0.02% 188
2018
Q3
$297K Hold
5,806
0.03% 194
2018
Q2
$313K Sell
5,806
-1,275
-18% -$70.4K 0.03% 198
2018
Q1
$365K Buy
+7,081
New +$394K 0.03% 171
2017
Q3
Sell
-8,290
Closed -$423K 205
2017
Q2
$423K Hold
8,290
0.04% 151
2017
Q1
$391K Buy
8,290
+320
+4% +$15K 0.03% 159
2016
Q4
$378K Sell
7,970
-420
-5% -$18.9K 0.03% 151
2016
Q3
$335K Sell
8,390
-2,573
-23% -$103K 0.03% 158
2016
Q2
$460K Buy
10,963
+2,080
+23% +$82.7K 0.04% 142
2016
Q1
$327K Buy
+8,883
New +$322K 0.03% 149

Other funds holding BNY

Aspiriant LLC's BNY Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Bank of New York Mellon (BNY) in Q2 2026: 1,435 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #381 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in BNY as recently as Q4 2019.

Aspiriant LLC first reported a position in BNY in Q1 2016 and has held it in 15 quarters since. The position peaked at $460K in Q2 2016. 348 funds tracked by Wall St. Rank hold BNY as of Q2 2026.

  • Aspiriant LLC held 1,435 shares of Bank of New York Mellon worth $208K as of Q2 2026.
  • Bank of New York Mellon was a new Aspiriant LLC position in Q2 2026.
  • Bank of New York Mellon made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #381 holding.
  • Aspiriant LLC first reported a position in Bank of New York Mellon in Q1 2016 and has held it in 15 quarters since.
  • Aspiriant LLC's Bank of New York Mellon position peaked at $460K in Q2 2016.
  • 348 funds tracked by Wall St. Rank held Bank of New York Mellon as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.